세계의 GLP-1 아날로그 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 기술 동향, 법규제 환경, 시장 규모 추이·예측, 각종 구분·지역별 상세 분석, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 개요
시장 전망
조사 범위
시장 요약
시장 역학과 성장요인
신규 기술
부문 분석
지역 분석
결론
제2장 시장 개요
개요
거시경제 요인의 분석
미국 관세의 제약 업계에 대한 영향
의료비
시장의 수요와 인구통계
Porter's Five Forces 분석
제3장 시장 역학
시장 역학
시장 성장 촉진요인
당뇨병과 비만의 증가
당뇨병의 진단과 치료 옵션에 관한 의식의 향상
강력한 연구개발 파이프라인
시장 성장 억제요인
제품 고장
신규 진출 기업에서의 높은 장벽
시장 기회
치료 용도의 확대
원격의료와 체중 관리 프로그램의 통합
제4장 규제 상황
규제 역학
미국
유럽
일본
중국
제5장 신규 기술과 파이프라인 분석
신규 동향/기술
차세대 멀티 수용체 작용제
혁신적인 약물전달 방법
치료 적응의 확대
파이프라인 분석
주요 포인트
특허 분석
주요 포인트
제6장 시장 부문 분석
세분화 내역
세계의 GLP-1 아날로그 시장 : 투여 경로별
주요 포인트
주사제
경구제
지역적 내역
세계의 GLP-1 아날로그 시장 : 지역별
주요 포인트
북미
유럽
아시아태평양
남미
중동 및 아프리카
제7장 경쟁 정보
주요 포인트
경쟁 구도
기업 점유율 분석
제8장 GLP-1 아날로그의 지속가능성 : ESG의 관점
ESG 입문
GLP-1 아날로그 시장에서의 지속가능성
ESG의 시점
환경에 대한 영향
사회에 대한 영향
거버넌스의 영향
결론
제9장 부록
조사 방법
전시
약어
기업 개요
HANSOH PHARMACEUTICAL GROUP CO. LTD.
LILLY USA LLC.
NOVO NORDISK A/S
SANOFI
SHANGHAI BENEMAE PHARMACEUTICAL CORP.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
신규 기업
KSA
영문 목차
영문목차
This report presents detailed information on glucagon-like peptide-1 (GLP-1) analogues. It examines market trends for GLP-1 analogues using data from 2024, estimates for 2025, and projected compound annual growth rates (CAGRs) through 2030 (the forecast period of 2025-2030). The report also covers regional markets for GLP-1 analogues. The GLP-1 analogue market is segmented by route of administration into oral and injection. By region, the market is divided into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.
Report Scope
This report provides detailed information on glucagon-like peptide-1 (GLP-1) analogues. It analyzes market trends for GLP-1 analogues, with data from 2024, estimates from 2025, projections of compound annual growth rates (CAGRs) through 2030 (the forecast period 2025-2030) and regional markets for GLP-1 analogues. This report highlights the current and future market potential of GLP-1 analogues and provides a detailed analysis of the competitive environment. It covers regulatory scenarios, drivers, restraints and opportunities, along with the market projections for 2030 and market share for key companies.
The GLP-1 analogue market is segmented by route of administration into oral and injection. By region, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The regional segment covers a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China and India. For market estimates, 2024 is used as the base year, with forecasts for 2025 and a projected value for 2030.
The report aims to:
Analyze the market for GLP-1 analogues.
Analyze the global market size and market segments.
Understand market constraints and drivers.
Provide detailed market forecasts for 2030.
Assess market share, competitiveness and industry structure.
Identify potential long-term impacts on the GLP-1 analogue market.
Report Includes
An overview of the current and future global markets for GLP-1 analogues
In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
Estimates of the size and revenue prospects of the global market, along with a market share analysis by route of administration, indication and region
Facts and figures pertaining to the market dynamics, technical advances, regulations and the impact of macroeconomic factors
An analysis of patents, emerging trends and developments in the industry
Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
Profiles of the leading companies
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Analysis of Macroeconomic Factors
Impact of U.S. Tariffs on the Pharmaceutical Industry
Healthcare Expenditure
Market Demand and Demographics
Porter's Five Forces Analysis
Bargaining Power of Buyers (High)
Bargaining Power of Suppliers (Moderate to High)
Potential for New Entrants (Low)
Threat of Substitutes (Moderate)
Competitiveness in the Industry (High)
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Cases of Diabetes and Obesity
Increasing Awareness of Diagnosis and Treatment Options for Diabetes
Strong R&D Pipeline
Market Restraints
Product Failure
High Barriers for New Entrants
Market Opportunities
Extended Therapeutic Uses
Integration in Telehealth and Weight Management Program
Chapter 4 Regulatory Landscape
Regulatory Dynamics
U.S.
Europe
Japan
China
Chapter 5 Emerging Technologies and Pipeline Analysis
Emerging Trends/Technologies
Next-Generation Multi-Receptor Agonists
Innovative Drug Delivery Methods
Expanded Therapeutic Indications
Pipeline Analysis
Key Takeaways
Patent Analysis
Key Takeaways
Chapter 6 Market Segment Analysis
Segmentation Breakdown
Global GLP-1 Analogues Market by Route of Administration
Key Takeaways
Injectable
Oral
Geographic Breakdown
Global GLP-1 Analogue Market by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Company Share Analysis
Chapter 8 Sustainability in GLP-1 Analogues: ESG Perspective
